Pfizer is trying to add $25 billion to its 2030 revenue through acquisitions. Dan Kitwood – WPA Pool/Getty Images Text size Pfizer ’s $5.4 billion deal to acquire the biotech Global Blood Therap...
Tag: Global Blood Therapeutics
What Stocks Are Moving Monday? Tesla, Palantir, First Solar and More.
Text size Tesla shares rise early Monday. (Photo by Justin Sullivan/Getty Images) Stock futures were trading higher Monday with investors assessing how aggressive the Federal Reserve will be in its ef...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...